Oruka Therapeutics (ORKA) Shareholder's Equity (2010 - 2026)

Oruka Therapeutics (ORKA) Shareholder's Equity (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Oruka Therapeutics 4.04 Bn 3.65 Bn - 486.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 486.72 Mn
Dec 31, 2025 471.93 Mn
Sep 30, 2025 486.79 Mn
Jun 30, 2025 343.64 Mn
Mar 31, 2025 364.73 Mn
Dec 31, 2024 382.22 Mn
Sep 30, 2024 342.37 Mn
Jun 30, 2024 -28.98 Mn
Mar 31, 2024 -7.06 Mn
Dec 31, 2023 37.02 Mn
Sep 30, 2023 37.97 Mn
Jun 30, 2023 39.24 Mn
Mar 31, 2023 40.53 Mn
Dec 31, 2022 41.67 Mn
Sep 30, 2022 42.73 Mn
Jun 30, 2022 44.96 Mn
Mar 31, 2022 47.94 Mn
Dec 31, 2021 51.04 Mn
Sep 30, 2021 56.60 Mn
Jun 30, 2021 61.21 Mn